Advertisement
Screener

Vaxart, Inc. (VXRT) Defined Contribution Plan, Administrative Expense

Vaxart, Inc. Defined Contribution Plan, Administrative Expense

Vaxart, Inc. (VXRT) reported Defined Contribution Plan, Administrative Expense of $30.00 thousand for the 12-month period ending 2025-12-31, per its S-1 filed 2026-05-08.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DefinedContributionPlanAdministrativeExpenses · last filed 2026-05-08

  • Vaxart, Inc. defined contribution plan, administrative expense for fiscal 2023 was $28.00K, a 47.37% increase from fiscal 2022.
  • Vaxart, Inc. defined contribution plan, administrative expense for fiscal 2022 was $19.00K, a 35.71% increase from fiscal 2021.
  • Vaxart, Inc. defined contribution plan, administrative expense for fiscal 2021 was $14.00K, a 40.00% increase from fiscal 2020.
  • Vaxart, Inc. defined contribution plan, administrative expense for fiscal 2020 was $10.00K, a 28.57% decline from fiscal 2019.
Period endDefined Contribution Plan, Administrative Expense 12 month
2025-12-31$30.00K
S-1 · filed 2026-05-08
2024-12-31$38.00K
S-1 · filed 2026-05-08
2023-12-31$28.00K
10-K · filed 2025-03-20
2022-12-31$19.00K
10-K · filed 2024-03-14
2021-12-31$14.00K
10-K · filed 2023-03-15
2020-12-31$10.00K
10-K · filed 2022-02-24
2019-12-31$14.00K
10-K · filed 2022-02-24
2018-12-31$9.00K
10-K · filed 2021-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
EXOZYMES INC. (EXOZ)United States$0.058B